MIMEDX GROUP, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $245.0m $321.1m $359.1m $299.3m $248.2m $258.6m $267.8m $321.5m $348.9m $418.6m
Cost of Revenue $32.4m $35.2m $36.4m $43.1m $39.3m $43.3m $48.3m $54.6m $60.1m $73.0m
Gross Profit $212.6m $285.9m $322.7m $256.2m $208.9m $215.3m $219.5m $266.8m $288.8m $345.6m
Operating expenses:
Operating Income (Loss) $18.4m $46.2m ($3.9m) ($21.2m) ($45.4m) ($5.0m) ($25.0m) $37.1m $58.9m $63.9m
Additional Financial Items
Amortization of Intangible Assets $2.1m $1.7m $1.0m $1.0m $1.1m $820k $701k $762k $765k $439k
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0
Income (Loss) from Continuing Operations, Per Basic Share $0 $1 ($0) ($0) ($1) ($0) ($0) $0 $0 $0
Income (Loss) from Continuing Operations, Per Diluted Share $0 $1 ($0) ($0) ($1) ($0) ($0) $0 $0 $0
Preferred Stock Dividends and Other Adjustments $6.6m $11.6m $0 $0
Preferred Stock Dividends, Income Statement Impact $6.8m $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $25.6m $61.5m ($10.0m) ($30.0m) $30.6m $57.3m $66.3m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $25.6m $61.5m $10.0m $30.0m $67.4m $42.0m $48.6m
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $2.0m $10.2m ($9.2m) $421k $0
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic $12.0m $64.7m ($30.0m) ($25.6m) ($49.3m) ($10.3m) ($30.2m) $55.8m $42.0m $48.6m
Net Income (Loss) Attributable to Parent $12.0m $64.7m ($30.0m) ($25.6m) ($49.3m) ($10.3m) ($30.2m) $58.2m $42.4m $48.6m
Net Income (Loss) Available to Common Stockholders, Basic $12.0m $64.7m ($30.0m) ($25.6m) ($83.3m) ($16.4m) ($36.8m) $55.8m $42.0m $48.6m
Earnings Per Share, Basic $0.11 $0.61 ($0.28) ($0.24) ($0.77) ($0.15) ($0.33) $0.40 $0.29 $0.33
Earnings Per Share, Diluted $0.11 $0.56 ($0.28) ($0.24) ($0.77) ($0.15) ($0.33) $0.37 $0.28 $0.32
Weighted Average Number of Shares Outstanding, Basic 105.9m 106.1m 105.6m 106.9m 108.3m 110.4m 112.9m 116.5m 147.0m 147.8m
Weighted Average Number of Shares Outstanding, Diluted 112.4m 116.1m 105.6m 106.9m 108.3m 110.4m 112.9m 146.0m 149.0m 149.7m
Research and Development Expense $12.0m $17.9m $15.8m $11.1m $11.7m $17.3m $22.8m $12.7m $12.3m $15.1m
General and Administrative Expense $49.5m $56.5m
Selling, General and Administrative Expense $180.0m $220.1m $258.5m $198.2m $181.0m $198.4m $208.8m $211.1m $225.1m $266.2m
Other Nonoperating Income (Expense) ($87k) $527k $283k ($3k) ($23k) ($4k) ($26k) ($565k) ($558k)
Interest Expense (non-operating) $3.9m $1.8m
Current Income Tax Expense (Benefit) $6.1m $7.0m $1.0m ($5k) ($12.3m) $247k $206k $998k $2.8m $9.0m
Interest Expense $339k
Selling and Marketing Expense $175.6m $209.7m
Income Tax Expense (Benefit) $6.1m ($19.6m) $26.6m ($5k) ($12.3m) $247k $206k ($36.8m) $15.3m $17.7m
Interest Income (Expense), Net ($4.7m) ($7.9m) ($5.0m) ($5.0m) ($6.5m) $1.0m $2.9m
Interest Income (Expense), Nonoperating, Net $5.0m $6.5m ($1.0m) $2.9m